Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TSH-activated signaling pathways in thyroid tumorigenesis.

Marcos Rivas1, Pilar Santisteban

  • 1Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier # 4, E-28029 Madrid, Spain.

Molecular and Cellular Endocrinology
|April 6, 2004
PubMed
Summary

Thyrotropin (TSH) signaling pathways regulate thyrocyte proliferation and are crucial for understanding thyroid pathology. This review details cAMP, Ras, and PLC/PKC pathways in thyroid tumor development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted radioiodine therapy of ovarian cancer via the sodium/iodide symporter (NIS).

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Expert Opinion to Optimize Clinical Outcomes of Bimatoprost Intracameral Implant Treatment.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice.

Drugs·2025
Same author

A Novel Missense Variant in the NKX2-1 <i>Homeodomain</i> Prevents Transcriptional Rescue by TAZ.

Thyroid : official journal of the American Thyroid Association·2024
Same author

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.

Nature communications·2024
Same author

Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma.

Current medical research and opinion·2024

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyrotropin (TSH) is the primary regulator of thyrocyte differentiation and proliferation.
  • Understanding TSH-mediated signaling is critical for elucidating thyroid pathology mechanisms.
  • Thyroid diseases often involve dysregulated thyrocyte growth and transformation.

Purpose of the Study:

  • To review the signaling pathways activated by TSH in thyrocytes.
  • To explore the role of these pathways in TSH-induced proliferation.
  • To examine the involvement of TSH signaling in thyroid tumorigenesis.

Main Methods:

  • Literature review focusing on TSH signaling pathways.
  • Analysis of cAMP-dependent protein kinase (PKA) pathways.

Related Experiment Videos

  • Investigation of alternative pathways including small GTPases (Rap1, Ras) and their effectors (PI3K, RalGDS, Raf).
  • Discussion of the phospholipase C (PLC)/protein kinase C (PKC) cascade.

    • Main Results:

    • TSH-mediated proliferation is largely driven by cyclic adenosine monophosphate (cAMP).
    • cAMP activates both protein kinase A (PKA)-dependent and independent processes influencing cell cycle progression.
    • Ras GTPase and its effectors (PI3K, RalGDS, Raf) play significant roles in TSH-induced proliferation and oncogenesis.
    • The PLC/PKC cascade is also activated by TSH, contributing to thyrocyte proliferation and tumor development.

    Conclusions:

    • TSH utilizes multiple signaling pathways, including cAMP/PKA, Ras, and PLC/PKC, to regulate thyrocyte proliferation.
    • These pathways are implicated in the initiation and progression of thyroid tumors.
    • Further characterization of TSH signaling is essential for understanding and potentially treating thyroid pathologies.